An arthritis drug that was being closely watched for its potential use against COVID-19 has delivered disappointing results in clinical trials. Kevzara, which is made by Regeneron and Sanofi, does not attack the novel coronavirus https://ift.tt/2W5j2YJ https://ift.tt/2KGJVgk https://ift.tt/2KGJVgk https://ift.tt/2Yi2dgd

https://ift.tt/2KGJVgk

Submitted April 27, 2020 at 09:09PM by DoremusJessup https://ift.tt/2Yi2dgd DoremusJessup